Evidence map›Paper›PMID 41228250›Full record

ArticleCancers2025

BALAD-2 Emerges as the Most Accurate Prognostic Model in Hepatocellular Carcinoma: Results from a Biobank-Based Cohort Study.

Coskun Ozer Demirtas, Fatih Eren, Demet Yilmaz Karadag, Yasemin Kaldirim Armutcuoglu, Tugba Tolu, Javid Huseyinov, Ugur Ciftci, Tuba Yilmaz, Sehnaz Akin, Feyza Dilber and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Coskun Ozer DemirtasDivision of Gastroenterology and Hepatology, School of Medicine, Marmara University, 34899 Istanbul, Türkiye.
Fatih ErenInstitute of Gastroenterology, Marmara University, 34854 Istanbul, Türkiye.ORCID 0000-0001-8126-2413
Demet Yilmaz KaradagInstitute of Gastroenterology, Marmara University, 34854 Istanbul, Türkiye.ORCID 0000-0001-5655-8538
Yasemin Kaldirim ArmutcuogluDivision of Gastroenterology and Hepatology, School of Medicine, Marmara University, 34899 Istanbul, Türkiye.
Tugba ToluDivision of Gastroenterology and Hepatology, School of Medicine, Marmara University, 34899 Istanbul, Türkiye.
Javid HuseyinovDivision of Gastroenterology and Hepatology, School of Medicine, Marmara University, 34899 Istanbul, Türkiye.
Ugur CiftciDivision of Gastroenterology and Hepatology, School of Medicine, Marmara University, 34899 Istanbul, Türkiye.
Tuba YilmazDivision of Gastroenterology and Hepatology, School of Medicine, Marmara University, 34899 Istanbul, Türkiye.
Sehnaz AkinDepartment of Internal Medicine, School of Medicine, Marmara University, 34854 Istanbul, Türkiye.
Feyza DilberDivision of Gastroenterology and Hepatology, School of Medicine, Marmara University, 34899 Istanbul, Türkiye.
Osman Cavit OzdoganDivision of Gastroenterology and Hepatology, School of Medicine, Marmara University, 34899 Istanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alfa-fetoproteinAlfa-fetoprotein-L3BALAD-2Des-gamma-carboxy prothrombinhepatocellular carcinoma

Identifiers

PMID41228250
PMCPMC12610203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.